Omar Gammoh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Omar Gammoh has a total of 186 co-authors. Here are the top co-authors by number of shared publications:
- Abdelrahim Alqudah
Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan
32 shared publications - Alaa A. A. Aljabali
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan
30 shared publications - Esam Qnais
Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa 13133, Jordan
25 shared publications - Murtaza M. Tambuwala
School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine BT52 1SA, UK
12 shared publications - Sireen Abdul Rahim Shilbayeh
Department of Pharmacy Practice, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia
12 shared publications - Mohammed Wedyan
Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa, Jordan
10 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (11) , 1589
From Formulation Quality to Anti-Tumor Immunity: A Multimodal Imaging and Translational Framework for mRNA–Lipid Nanoparticle Cancer Vaccines in Preclinical Tumor Models
MRNA–Lipid nanoparticles (LNPs) for cancer vaccines are often considered a linear progression, in which formulation, biodistribution, innate stimulation, antigen expression, and tumor control form a continuum. They are not. This review connects the manufacturing inputs and lipid composition to particle attributes, innate sensing, organ and cell exposure, cytosolic translation, antigen presentation, therapeutic response, and hepatic safety. This review aims to provide a mechanism-aligned framework from critical quality attributes (CQAs) and critical process parameters (CPPs) to innate sensing, multimodal imaging, and preclinical efficacy and safety that can be used to design and interpret preclinical studies of mRNA-LNP cancer vaccines, with explicit attention to orthotopic pancreatic ductal adenocarcinoma (PDAC) models. Principal findings: (i) total organ signal is an inadequate surrogate for productive delivery; the decisive variable is translation of antigen in a permissive antigen-presenting cell (APC) during a defined inflammatory window; (ii) formulation and process variables including size, PDI, encapsulation, RNA integrity and capping, lipid composition, PEG-lipid architecture, mixing conditions, and storage history alter this conversion; and (iii) multimodal imaging is most informative when carrier or payload tracking is paired with reporter or antigen expression, immune profiling, tumor response, and liver-safety assays. We propose a release-to-response architecture for preclinical studies and identify the evidence required for clinically interpretable pharmacology. We reviewed peer-reviewed studies on mRNA cancer vaccination, quantitative imaging, PDAC models, LNP quality-by-design, and formulation-dependent innate immunology. The total organ signal is an inadequate surrogate for productive delivery; the decisive variable is translating antigen into an antigen-presenting cell during a permissive inflammatory window. Particle size, polydispersity, encapsulation, RNA integrity and capping, lipid composition, PEG-lipid architecture, mixing conditions, and storage history can alter this conversion. Multimodal imaging is most informative when carrier or payload tracking is paired with reporter or antigen expression, immune profiling, tumor response, and liver safety assays. PDAC studies have shown that hepatic or splenic exposure can be either a liability or intentional immune reprogramming. We propose a release-to-response architecture for preclinical studies and identify the evidence required for clinically interpretable pharmacology.
- 1 November 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (11) , 1589
Open AccessFrom Formulation Quality to Anti-Tumor Immunity: A Multimodal Imaging and Translational Framework for mRNA–Lipid Nanoparticle Cancer Vaccines in Preclinical Tumor Models
MRNA–Lipid nanoparticles (LNPs) for cancer vaccines are often considered a linear progression, in which formulation, biodistribution, innate stimulation, antigen expression, and tumor control form a continuum. They are not. This review connects the manufacturing inputs and lipid composition to particle attributes, innate sensing, organ and cell exposure, cytosolic translation, antigen presentation, therapeutic response, and hepatic safety. This review aims to provide a mechanism-aligned framework from critical quality attributes (CQAs) and critical process parameters (CPPs) to innate sensing, multimodal imaging, and preclinical efficacy and safety that can be used to design and interpret preclinical studies of mRNA-LNP cancer vaccines, with explicit attention to orthotopic pancreatic ductal adenocarcinoma (PDAC) models. Principal findings: (i) total organ signal is an inadequate surrogate for productive delivery; the decisive variable is translation of antigen in a permissive antigen-presenting cell (APC) during a defined inflammatory window; (ii) formulation and process variables including size, PDI, encapsulation, RNA integrity and capping, lipid composition, PEG-lipid architecture, mixing conditions, and storage history alter this conversion; and (iii) multimodal imaging is most informative when carrier or payload tracking is paired with reporter or antigen expression, immune profiling, tumor response, and liver-safety assays. We propose a release-to-response architecture for preclinical studies and identify the evidence required for clinically interpretable pharmacology. We reviewed peer-reviewed studies on mRNA cancer vaccination, quantitative imaging, PDAC models, LNP quality-by-design, and formulation-dependent innate immunology. The total organ signal is an inadequate surrogate for productive delivery; the decisive variable is translating antigen into an antigen-presenting cell during a permissive inflammatory window. Particle size, polydispersity, encapsulation, RNA integrity and capping, lipid composition, PEG-lipid architecture, mixing conditions, and storage history can alter this conversion. Multimodal imaging is most informative when carrier or payload tracking is paired with reporter or antigen expression, immune profiling, tumor response, and liver safety assays. PDAC studies have shown that hepatic or splenic exposure can be either a liability or intentional immune reprogramming. We propose a release-to-response architecture for preclinical studies and identify the evidence required for clinically interpretable pharmacology.
- Open Access
CAR T-Cell Therapy in Hematological Malignancies: Mechanisms, Innovations, and Challenges
Chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment of relapsed or refractory hematological malignancies, producing deep and durable responses in B-cell acute lymphoblastic leukemia, aggressive B-cell non-Hodgkin lymphomas, and multiple myeloma. Nevertheless, antigen escape, limited in vivo persistence, T-cell exhaustion, and toxicities such as cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) limit broader application. This review synthesizes the mechanistic basis and clinical evidence for the currently approved CAR T-cell products and examines engineering strategies designed to overcome these barriers, including “armored” CAR T cells, multitargeted and logic-gated constructs, and modular or universal platforms intended to extend this approach beyond CD19-positive disease. Combination strategies with immune checkpoint inhibitors, radiotherapy, and other immunotherapies are discussed, together with emerging biomarkers of response and toxicity. Continued optimization of CAR design, toxicity management, and manufacturing scalability will be essential for CAR T-cell therapy to become a foundational pillar of precision oncology.
Open AccessCAR T-Cell Therapy in Hematological Malignancies: Mechanisms, Innovations, and Challenges
Chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment of relapsed or refractory hematological malignancies, producing deep and durable responses in B-cell acute lymphoblastic leukemia, aggressive B-cell non-Hodgkin lymphomas, and multiple myeloma. Nevertheless, antigen escape, limited in vivo persistence, T-cell exhaustion, and toxicities such as cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) limit broader application. This review synthesizes the mechanistic basis and clinical evidence for the currently approved CAR T-cell products and examines engineering strategies designed to overcome these barriers, including “armored” CAR T cells, multitargeted and logic-gated constructs, and modular or universal platforms intended to extend this approach beyond CD19-positive disease. Combination strategies with immune checkpoint inhibitors, radiotherapy, and other immunotherapies are discussed, together with emerging biomarkers of response and toxicity. Continued optimization of CAR design, toxicity management, and manufacturing scalability will be essential for CAR T-cell therapy to become a foundational pillar of precision oncology.
- Open Access
- 28 April 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (9) , 1174
Adult ADHD Symptoms in Syrian War Refugees with Long-Term Health Conditions: A Screening Cross-Sectional Analysis from Jordan
Background/Objectives: Attention-deficit hyperactivity disorder (ADHD) in adults is often overlooked in refugees, especially those displaced by war and diagnosed with chronic issues such as hypertension and type 2 diabetes mellitus. We sought to provide a preliminary screening to align with ADHD screening and to examine its related demographic and clinical factors. Methods: This cross-sectional study recruited Syrian refugees residing in Jordan. The Adult ADHD Self-Report Scale-V1.1 (ASRS) was employed to provide a preliminary screening of “Consistency with ADHD screening”. Multivariable regression analysis was used to identify the risk factors associated with the “Consistency with ADHD screening”. Results: Data analysis included 345 patients; 179 (51.9%) were females. β-Blockers were used in 151 (43.8%), metformin in 134 (38.8%), and sulfonylurea in 86 (24.9%). In the study, 158 participants (45.8%) reported very consistent results related to ADHD. We used multivariate binary logistic regression, which showed that in our groups that received metformin (OR of 2.08, 95% CI 1.32–3.27, p = 0.001) and insulin (OR of 2.25, 95% CI 1.00–5.04, p = 0.04), we observed a positive association with ADHD symptoms. Also, we noted that high school education was negatively associated with the results of the ADHD screen (OR of 0.58, 95% CI of 0.36–0.94, p = 0.02). Conclusions: This preliminary study guides future steps in addressing ADHD symptoms in war-displaced refugees; proper diabetes management and education seem to be important factors.
- 28 April 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (9) , 1174
Open AccessAdult ADHD Symptoms in Syrian War Refugees with Long-Term Health Conditions: A Screening Cross-Sectional Analysis from Jordan
Background/Objectives: Attention-deficit hyperactivity disorder (ADHD) in adults is often overlooked in refugees, especially those displaced by war and diagnosed with chronic issues such as hypertension and type 2 diabetes mellitus. We sought to provide a preliminary screening to align with ADHD screening and to examine its related demographic and clinical factors. Methods: This cross-sectional study recruited Syrian refugees residing in Jordan. The Adult ADHD Self-Report Scale-V1.1 (ASRS) was employed to provide a preliminary screening of “Consistency with ADHD screening”. Multivariable regression analysis was used to identify the risk factors associated with the “Consistency with ADHD screening”. Results: Data analysis included 345 patients; 179 (51.9%) were females. β-Blockers were used in 151 (43.8%), metformin in 134 (38.8%), and sulfonylurea in 86 (24.9%). In the study, 158 participants (45.8%) reported very consistent results related to ADHD. We used multivariate binary logistic regression, which showed that in our groups that received metformin (OR of 2.08, 95% CI 1.32–3.27, p = 0.001) and insulin (OR of 2.25, 95% CI 1.00–5.04, p = 0.04), we observed a positive association with ADHD symptoms. Also, we noted that high school education was negatively associated with the results of the ADHD screen (OR of 0.58, 95% CI of 0.36–0.94, p = 0.02). Conclusions: This preliminary study guides future steps in addressing ADHD symptoms in war-displaced refugees; proper diabetes management and education seem to be important factors.
- 24 February 2026
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 138 (4)
Isorhamnetin Protects Against Organophosphate‐Induced Cardiac Damage in Wistar Rats Through Redox Balance and Nrf2/HO‐1 Signalling
Background: Chlorpyrifos (CPF) triggers cardiotoxicity associated with oxidative stress, inflammation and apoptosis. This study investigated whether isorhamnetin, a chemically defined flavonol (3′‐ O ‐methylquercetin, C 16 H 12 O 7 , purity ≥ 98%), could mitigate CPF‐induced myocardial injury. Methods: Male Wistar rats were randomly divided into control, isorhamnetin, CPF and CPF + isorhamnetin groups. Cardiac biomarkers, oxidative/antioxidant status, and inflammatory and apoptotic mediators in conjunction with histopathology and Nrf2/HO‐1 signalization were assessed. Results: CPF elevated serum cTnI, CK‐MB and LDH ( p < 0.001), attaining lower levels after isorhamnetin cotreatment ( p < 0.001). TBARS and NO were elevated ( p < 0.001), whereas GSH, SOD, catalase and GPx decreased ( p < 0.001) after CPF exposure; these indices were reverted with isorhamnetin. CPF increased the expression levels of NF‐κB p65, TNF‐α, IL‐6 and IL‐1β proteins and decreased that of IL‐10 ( p < 0.001), whereas isorhamnetin offset these effects ( p < 0.001). Apoptosis was apparent with high Bax and caspase‐3 and low Bcl‐2 ( p < 0.001); all were ameliorated by isorhamnetin. Histopathological alterations caused by CPF were ameliorated. CPF downregulated the expression and activity of Nrf2/HO‐1 ( p < 0.001), but this pathway was significantly induced by isorhamnetin ( p < 0.001). Conclusions: Isorhamnetin alleviates CPF‐induced cardiotoxicity by restoring redox balance and modulating inflammatory and apoptotic pathways through Nrf2/HO‐1 signalling.
- 24 February 2026
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 138 (4)
Isorhamnetin Protects Against Organophosphate‐Induced Cardiac Damage in Wistar Rats Through Redox Balance and Nrf2/HO‐1 Signalling
Background: Chlorpyrifos (CPF) triggers cardiotoxicity associated with oxidative stress, inflammation and apoptosis. This study investigated whether isorhamnetin, a chemically defined flavonol (3′‐ O ‐methylquercetin, C 16 H 12 O 7 , purity ≥ 98%), could mitigate CPF‐induced myocardial injury. Methods: Male Wistar rats were randomly divided into control, isorhamnetin, CPF and CPF + isorhamnetin groups. Cardiac biomarkers, oxidative/antioxidant status, and inflammatory and apoptotic mediators in conjunction with histopathology and Nrf2/HO‐1 signalization were assessed. Results: CPF elevated serum cTnI, CK‐MB and LDH ( p < 0.001), attaining lower levels after isorhamnetin cotreatment ( p < 0.001). TBARS and NO were elevated ( p < 0.001), whereas GSH, SOD, catalase and GPx decreased ( p < 0.001) after CPF exposure; these indices were reverted with isorhamnetin. CPF increased the expression levels of NF‐κB p65, TNF‐α, IL‐6 and IL‐1β proteins and decreased that of IL‐10 ( p < 0.001), whereas isorhamnetin offset these effects ( p < 0.001). Apoptosis was apparent with high Bax and caspase‐3 and low Bcl‐2 ( p < 0.001); all were ameliorated by isorhamnetin. Histopathological alterations caused by CPF were ameliorated. CPF downregulated the expression and activity of Nrf2/HO‐1 ( p < 0.001), but this pathway was significantly induced by isorhamnetin ( p < 0.001). Conclusions: Isorhamnetin alleviates CPF‐induced cardiotoxicity by restoring redox balance and modulating inflammatory and apoptotic pathways through Nrf2/HO‐1 signalling.
- Open Access
- 21 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 880
Psychological Resilience in Individuals with Type 2 Diabetes Mellitus in Jordan Is Associated with Insomnia Severity: A Cross-Sectional Analysis
Background/Objectives: Although psychological resilience is an important factor related to mental health outcomes, it is understudied in patients with long-term health conditions in developing countries such as Jordan. Type 2 diabetes mellitus (T2DM) is rapidly increasing in Jordan; thus, its prevalence and correlation with psychological resilience are worth investigating. Through this study, we aimed to estimate the prevalence of psychological resilience levels and identify their associated factors in people with T2DM in Jordan based on demographic data, clinical data, and insomnia severity. Methods: Participants were sampled from the patient register of the Royal Health Awareness Society (RHAS), which permitted access to people receiving T2DM-related services. Results: Data from 350 individuals with T2DM were analyzed; 185 (52.9%) were female, 276 (78.9%) were over 50 years of age, and 308 (88%) were married. In total, 56 (16%) people reported moderate–severe insomnia, and 64 (18.3%) reported low resilience. Being more resilient was found to correlate with “being married” (OR = 3.33, 95% CI (1.60–6.89), p = 0.001) but was negatively correlated with “moderate–severe insomnia” (OR = 0.21, 95% CI (0.11–0.40), p < 0.001). Conclusions: Addressing insomnia in individuals with T2DM is warranted to improve their resilience levels, thus promoting their mental health.
- 21 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 880
Open AccessPsychological Resilience in Individuals with Type 2 Diabetes Mellitus in Jordan Is Associated with Insomnia Severity: A Cross-Sectional Analysis
Background/Objectives: Although psychological resilience is an important factor related to mental health outcomes, it is understudied in patients with long-term health conditions in developing countries such as Jordan. Type 2 diabetes mellitus (T2DM) is rapidly increasing in Jordan; thus, its prevalence and correlation with psychological resilience are worth investigating. Through this study, we aimed to estimate the prevalence of psychological resilience levels and identify their associated factors in people with T2DM in Jordan based on demographic data, clinical data, and insomnia severity. Methods: Participants were sampled from the patient register of the Royal Health Awareness Society (RHAS), which permitted access to people receiving T2DM-related services. Results: Data from 350 individuals with T2DM were analyzed; 185 (52.9%) were female, 276 (78.9%) were over 50 years of age, and 308 (88%) were married. In total, 56 (16%) people reported moderate–severe insomnia, and 64 (18.3%) reported low resilience. Being more resilient was found to correlate with “being married” (OR = 3.33, 95% CI (1.60–6.89), p = 0.001) but was negatively correlated with “moderate–severe insomnia” (OR = 0.21, 95% CI (0.11–0.40), p < 0.001). Conclusions: Addressing insomnia in individuals with T2DM is warranted to improve their resilience levels, thus promoting their mental health.
- 4 January 2026
- Published by Wiley in Drug Development Research
- Vol. 87 (1) , e70195
Protective Effects of Herbacetin in Experimental Colitis: Targeting NF‐κB and NLRP3 Pathways
Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) resulting from a dysregulation of immune responses. Herbacetin, a flavonoid of natural origin, has been found to exert an anti‐inflammatory action, though its actions in experimental colitis are unknown. Colitis was induced in BALB/c mice with 2,4,6‐trinitrobenzenesulfonic acid (TNBS). Mice were administered with herbacetin (25, 50, 100 mg/kg) or sulfasalazine (100 mg/kg) orally for 7 days. The disease activity index (DAI), colon length, weight/length ratio, histopathology, MPO and NO contents, and inflammatory gene expression (NF‐κB, iNOS, COX‐2, NLRP3, IL‐1β, IL‐18) were evaluated. TNBS induced marked weight loss and increased DAI ( p < 0.01 vs. NC). Body weight ( p < 0.01) and DAI ( p < 0.01) were significantly ameliorated by herbacetin, especially at 50 and 100 mg/kg. TNBS significantly reduced the colon length ( p < 0.001) and increased the weight/length ratio ( p < 0.001), which were significantly counteracted by herbacetin ( p < 0.01–0.001). TNBS mice presented with mucosal injury and inflammatory infiltration were demonstrated by histopathology ( p < 0.001) and a dose‐dependent healing effect was observed in herbacetin‐treated mice. TNBS mice had higher levels of MPO and NO ( p < 0.001), which were significantly attenuated by herbacetin ( p < 0.01–0.001). Herbacetin decreased the mRNA expression levels of NF‐κB, iNOS, COX‐2, NLRP3, IL‐1β, and IL‐18 in a dose‐dependent ( p < 0.05–0.001). Herbacetin exerts a protective effect in colitis by suppressing neutrophil infiltration, oxidative stress, and NF‐κB–NLRP3‐mediated inflammation, highlighting the potential of herbacetin‐based treatment for UC and related inflammatory bowel diseases.
- 4 January 2026
- Published by Wiley in Drug Development Research
- Vol. 87 (1) , e70195
Protective Effects of Herbacetin in Experimental Colitis: Targeting NF‐κB and NLRP3 Pathways
Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) resulting from a dysregulation of immune responses. Herbacetin, a flavonoid of natural origin, has been found to exert an anti‐inflammatory action, though its actions in experimental colitis are unknown. Colitis was induced in BALB/c mice with 2,4,6‐trinitrobenzenesulfonic acid (TNBS). Mice were administered with herbacetin (25, 50, 100 mg/kg) or sulfasalazine (100 mg/kg) orally for 7 days. The disease activity index (DAI), colon length, weight/length ratio, histopathology, MPO and NO contents, and inflammatory gene expression (NF‐κB, iNOS, COX‐2, NLRP3, IL‐1β, IL‐18) were evaluated. TNBS induced marked weight loss and increased DAI ( p < 0.01 vs. NC). Body weight ( p < 0.01) and DAI ( p < 0.01) were significantly ameliorated by herbacetin, especially at 50 and 100 mg/kg. TNBS significantly reduced the colon length ( p < 0.001) and increased the weight/length ratio ( p < 0.001), which were significantly counteracted by herbacetin ( p < 0.01–0.001). TNBS mice presented with mucosal injury and inflammatory infiltration were demonstrated by histopathology ( p < 0.001) and a dose‐dependent healing effect was observed in herbacetin‐treated mice. TNBS mice had higher levels of MPO and NO ( p < 0.001), which were significantly attenuated by herbacetin ( p < 0.01–0.001). Herbacetin decreased the mRNA expression levels of NF‐κB, iNOS, COX‐2, NLRP3, IL‐1β, and IL‐18 in a dose‐dependent ( p < 0.05–0.001). Herbacetin exerts a protective effect in colitis by suppressing neutrophil infiltration, oxidative stress, and NF‐κB–NLRP3‐mediated inflammation, highlighting the potential of herbacetin‐based treatment for UC and related inflammatory bowel diseases.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2026 (1)
Adherence to Ischemic Stroke Management Guidelines Among Healthcare Providers in Jordanian Hospitals: A Cross‐Sectional Study
Background: A stroke is a neurological condition caused by the sudden and localized impairment of neurological function due to vascular causes, infarction, or hemorrhage. The management of ischemic stroke necessitates adherence to international guidelines to ensure the best practices. This study aims to explore the level of implementation of ischemic stroke management guidelines among physicians and nurses in Jordanian hospitals, as well as perceived barriers and suggested strategies for improvement. Methods: A cross‐sectional descriptive research method was used. A self‐reporting questionnaire, designed based on the recent guidelines of AHA/ASA and ESO, and validated through an expert panel, was administered between the months of August and September 2023. The medical files of patients admitted for acute ischemic stroke from the period of March to July 2023 were reviewed retrospectively. Convenience sampling method was used to recruit 40 physicians and 120 nurses from three hospitals, whereas 150 participants were selected randomly for analysis. Results: More than half of the physicians (57.2%) stated that they used first‐line intravenous thrombolysis properly. Results on acute stroke assessment and management pathways in the emergency department showed moderate compliance ( M = 1.38/3, SD = 0.49). In addition, mechanical thrombectomy procedures were not carried out for the reason that they were not available. Provision of healthy lifestyles showed higher results among physicians ( M = 2.52/4, SD = 0.55) than nurses. Results on nurses’ compliance with guideline‐recommended stroke management practices on post‐stroke patient care within the hospital ( M = 1.45/3, SD = 0.67) and healthy lifestyles ( M = 1.99/4, SD = 0.70) were moderate. Barriers that were identified included patients’ delayed presentation beyond the thrombolytic window and lack of sufficient insurance benefits. Respondents identified issues that needed governmental support and education to promote implementation. The analysis of the medical record showed some significant problems in the adherence to the stroke management protocols. First, the NIHSS score assessment was completed in 16.7% of the patients; the advanced vascular imaging (CTA/MRA) was performed in 16% of the patients; the thrombolysis was provided for 2.7% of the patients; and no mechanical thrombectomy procedures were carried out in the study group. Although most patients received proper discharge medications education, documentation of lifestyle counseling and secondary prevention advice was inadequate, suggesting inadequate stroke assessment, acute management, and patient education. Conclusion: The present descriptive cross‐sectional study illustrates partial‐to‐moderate compliance with international guidelines for management of acute ischemic stroke in the participating Jordanian hospitals. It seems that higher compliance levels were found related to lifestyle changes and secondary prevention interventions than with certain processes of managing acute stroke patients, whereas no mechanical thrombectomy procedure was recorded in the analyzed medical records. The results of this study shed light on implementation patterns and barriers faced by participating hospitals and could potentially be used when developing quality improvement initiatives; however, it is not about cause‐and‐effect relations or testing an intervention’s effectiveness.
- 1 January 2026
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2026 (1)
Open AccessAdherence to Ischemic Stroke Management Guidelines Among Healthcare Providers in Jordanian Hospitals: A Cross‐Sectional Study
Background: A stroke is a neurological condition caused by the sudden and localized impairment of neurological function due to vascular causes, infarction, or hemorrhage. The management of ischemic stroke necessitates adherence to international guidelines to ensure the best practices. This study aims to explore the level of implementation of ischemic stroke management guidelines among physicians and nurses in Jordanian hospitals, as well as perceived barriers and suggested strategies for improvement. Methods: A cross‐sectional descriptive research method was used. A self‐reporting questionnaire, designed based on the recent guidelines of AHA/ASA and ESO, and validated through an expert panel, was administered between the months of August and September 2023. The medical files of patients admitted for acute ischemic stroke from the period of March to July 2023 were reviewed retrospectively. Convenience sampling method was used to recruit 40 physicians and 120 nurses from three hospitals, whereas 150 participants were selected randomly for analysis. Results: More than half of the physicians (57.2%) stated that they used first‐line intravenous thrombolysis properly. Results on acute stroke assessment and management pathways in the emergency department showed moderate compliance ( M = 1.38/3, SD = 0.49). In addition, mechanical thrombectomy procedures were not carried out for the reason that they were not available. Provision of healthy lifestyles showed higher results among physicians ( M = 2.52/4, SD = 0.55) than nurses. Results on nurses’ compliance with guideline‐recommended stroke management practices on post‐stroke patient care within the hospital ( M = 1.45/3, SD = 0.67) and healthy lifestyles ( M = 1.99/4, SD = 0.70) were moderate. Barriers that were identified included patients’ delayed presentation beyond the thrombolytic window and lack of sufficient insurance benefits. Respondents identified issues that needed governmental support and education to promote implementation. The analysis of the medical record showed some significant problems in the adherence to the stroke management protocols. First, the NIHSS score assessment was completed in 16.7% of the patients; the advanced vascular imaging (CTA/MRA) was performed in 16% of the patients; the thrombolysis was provided for 2.7% of the patients; and no mechanical thrombectomy procedures were carried out in the study group. Although most patients received proper discharge medications education, documentation of lifestyle counseling and secondary prevention advice was inadequate, suggesting inadequate stroke assessment, acute management, and patient education. Conclusion: The present descriptive cross‐sectional study illustrates partial‐to‐moderate compliance with international guidelines for management of acute ischemic stroke in the participating Jordanian hospitals. It seems that higher compliance levels were found related to lifestyle changes and secondary prevention interventions than with certain processes of managing acute stroke patients, whereas no mechanical thrombectomy procedure was recorded in the analyzed medical records. The results of this study shed light on implementation patterns and barriers faced by participating hospitals and could potentially be used when developing quality improvement initiatives; however, it is not about cause‐and‐effect relations or testing an intervention’s effectiveness.
- Open Access
- 1 January 2026
- Published by SAGE Publications in SAGE Open Nursing
- Vol. 12
Beyond the Prescription: Association Between Illness Perception and Medication Adherence in Chronic Obstructive Pulmonary Disease Patients in Jordan
Background: Chronic obstructive pulmonary disease (COPD) remains a pressing global health challenge, characterized by progressive respiratory impairment and substantial impacts on quality of life. Objectives: This study aimed to examine the level of medication adherence among patients with COPD in Jordan and explore the relationship between medication adherence and illness perception (IP) among patients with COPD in Jordan. Materials and Methods: A cross-sectional, correlational design was used to recruit a convenience sample utilizing the Medication Adherence Report Scale Questionnaire (MARS-5), and the Brief Illness Perception Questionnaire (Brief IPQ) was utilized. The study was conducted in the outpatient pulmonary clinics of four major referral hospitals in Jordan. Results: The study involved 169 COPD patients, with a majority being married and male. Most had bachelor's degrees, making between 300 and 500 Jordanian Dinar. 39.1% had 1–3 family members, with 66 reporting family members. The study used a medication adherence reporting scale to evaluate patients’ medication adherence. The mean score was 23.17, with 91.1% of COPD patients adhering to their treatment regimen, while 8.9% were non-adherent. The majority were unlikely to forget, alter dosage, discontinue, skip doses, or use less than prescribed. The study found that timeline acute/chronic, consequences, personal control, treatment control, coherence, and timeline cyclical positively correlated with the MARS-5 mean score, indicating high scores correlate with high medication adherence, while emotional representation had no significant correlation. Conclusion: The study found that COPD patients in Jordan demonstrated high medication adherence and generally positive IPs, particularly regarding treatment effectiveness, illness coherence, and personal control. These findings underscore the importance of patient-centered education and supportive interventions to enhance adherence and self-management.
- 1 January 2026
- Published by SAGE Publications in SAGE Open Nursing
- Vol. 12
Open AccessBeyond the Prescription: Association Between Illness Perception and Medication Adherence in Chronic Obstructive Pulmonary Disease Patients in Jordan
Background: Chronic obstructive pulmonary disease (COPD) remains a pressing global health challenge, characterized by progressive respiratory impairment and substantial impacts on quality of life. Objectives: This study aimed to examine the level of medication adherence among patients with COPD in Jordan and explore the relationship between medication adherence and illness perception (IP) among patients with COPD in Jordan. Materials and Methods: A cross-sectional, correlational design was used to recruit a convenience sample utilizing the Medication Adherence Report Scale Questionnaire (MARS-5), and the Brief Illness Perception Questionnaire (Brief IPQ) was utilized. The study was conducted in the outpatient pulmonary clinics of four major referral hospitals in Jordan. Results: The study involved 169 COPD patients, with a majority being married and male. Most had bachelor's degrees, making between 300 and 500 Jordanian Dinar. 39.1% had 1–3 family members, with 66 reporting family members. The study used a medication adherence reporting scale to evaluate patients’ medication adherence. The mean score was 23.17, with 91.1% of COPD patients adhering to their treatment regimen, while 8.9% were non-adherent. The majority were unlikely to forget, alter dosage, discontinue, skip doses, or use less than prescribed. The study found that timeline acute/chronic, consequences, personal control, treatment control, coherence, and timeline cyclical positively correlated with the MARS-5 mean score, indicating high scores correlate with high medication adherence, while emotional representation had no significant correlation. Conclusion: The study found that COPD patients in Jordan demonstrated high medication adherence and generally positive IPs, particularly regarding treatment effectiveness, illness coherence, and personal control. These findings underscore the importance of patient-centered education and supportive interventions to enhance adherence and self-management.
- Open Access
- 12 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (50) , e46563
Resilience in people with epilepsy in Jordan: an interplay between demographics, clinical variables, and insomnia? A cross-sectional study
Although resilience among people with epilepsy (PWE) is important to maintain adequate mental health, however, it has not been unstudied in Jordan. The current study aims to identify the correlates of lower resilience among a cohort of PWE in Jordan, with an emphasis on the demographic variables, clinical variables, and insomnia. This cross-sectional study recruited PWE from Al-Bashir Hospital-Jordan used validated scales for insomnia and resilience. Data from 104 PWE showed that 56 (53.8%) were males, 59 (56.7%) were aged between 18 to 29 years old, and 65 (62.5%) were single. Furthermore, only 9 (8.6%) of the sample received a university education, 60 (57.7%) received a high school education, and 35 (33.6%) received an elementary education. Also, unemployment was evident in 76 (73.1%), and smoking in 37 (35.6%) of the PWE. Also, moderate/severe insomnia was reported in 43 (41.3%), and poor resilience in 54 (51.4%) of the PWE. The multivariable binary logistic regression analysis demonstrated that PWE with lower education showed lower odds (odd ratio = 0.43, 95% CI = 0.22–0.86, P = .02) for resilience. Although the current investigation underscored the importance of education in resilience, however, further larger-scale studies have to be pursued to uncover and address other risk factors.
- 12 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (50) , e46563
Open AccessResilience in people with epilepsy in Jordan: an interplay between demographics, clinical variables, and insomnia? A cross-sectional study
Although resilience among people with epilepsy (PWE) is important to maintain adequate mental health, however, it has not been unstudied in Jordan. The current study aims to identify the correlates of lower resilience among a cohort of PWE in Jordan, with an emphasis on the demographic variables, clinical variables, and insomnia. This cross-sectional study recruited PWE from Al-Bashir Hospital-Jordan used validated scales for insomnia and resilience. Data from 104 PWE showed that 56 (53.8%) were males, 59 (56.7%) were aged between 18 to 29 years old, and 65 (62.5%) were single. Furthermore, only 9 (8.6%) of the sample received a university education, 60 (57.7%) received a high school education, and 35 (33.6%) received an elementary education. Also, unemployment was evident in 76 (73.1%), and smoking in 37 (35.6%) of the PWE. Also, moderate/severe insomnia was reported in 43 (41.3%), and poor resilience in 54 (51.4%) of the PWE. The multivariable binary logistic regression analysis demonstrated that PWE with lower education showed lower odds (odd ratio = 0.43, 95% CI = 0.22–0.86, P = .02) for resilience. Although the current investigation underscored the importance of education in resilience, however, further larger-scale studies have to be pursued to uncover and address other risk factors.
- Open Access
- 29 November 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 216
Isorhamnetin Alleviates Early-Life Stress-Induced Anxiety and Depression in Male Mice: Neuroinflammatory Modulation and Sirt1/NF-κB Signaling Insights
Offsprings early separated from their mothers may display depression and anxiety behaviors. The objective of this study is to assess the potential of isorhmanetin, known for its anti-inflammatory and antidepressant properties, in mitigating these behaviors in male mice. The experimental mice underwent a 4-h daily maternal separation from postnatal days 2 to 21. Afterwards, mice were given an intraperitoneal injection of isorhamnetin (20 mg/kg/day) from postnatal day 61 for 4 weeks. At 3 months old, both behavioral evaluations and biochemical analyses were carried out. The findings indicated that the isolated mice displayed clear signs of anxiety and depression-like behaviors, along with increased levels of various cytokines (IL-1β, IL-6, and TNF-α) in the hippocampus and decreased levels of Sirt1, accompanied by elevated NF-κB p65 expression. The effects were mitigated by treatment with isorhamnetin, resulting in the normalization of behavior and cytokine levels, as well as the activation of Sirt1 expression in addition to downregulation of NF-κB p65. Isorhamnetin has the potential to be utilized as a treatment for anxiety and depression-like symptoms by adjusting pathways of neuroinflammation and the signaling axis of Sirt1 and NF-κB. This opens the door for further investigation in mitigating the biochemical and behavioral adverse effects induced by separation during the maternal period.
- 29 November 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 216
Open AccessIsorhamnetin Alleviates Early-Life Stress-Induced Anxiety and Depression in Male Mice: Neuroinflammatory Modulation and Sirt1/NF-κB Signaling Insights
Offsprings early separated from their mothers may display depression and anxiety behaviors. The objective of this study is to assess the potential of isorhmanetin, known for its anti-inflammatory and antidepressant properties, in mitigating these behaviors in male mice. The experimental mice underwent a 4-h daily maternal separation from postnatal days 2 to 21. Afterwards, mice were given an intraperitoneal injection of isorhamnetin (20 mg/kg/day) from postnatal day 61 for 4 weeks. At 3 months old, both behavioral evaluations and biochemical analyses were carried out. The findings indicated that the isolated mice displayed clear signs of anxiety and depression-like behaviors, along with increased levels of various cytokines (IL-1β, IL-6, and TNF-α) in the hippocampus and decreased levels of Sirt1, accompanied by elevated NF-κB p65 expression. The effects were mitigated by treatment with isorhamnetin, resulting in the normalization of behavior and cytokine levels, as well as the activation of Sirt1 expression in addition to downregulation of NF-κB p65. Isorhamnetin has the potential to be utilized as a treatment for anxiety and depression-like symptoms by adjusting pathways of neuroinflammation and the signaling axis of Sirt1 and NF-κB. This opens the door for further investigation in mitigating the biochemical and behavioral adverse effects induced by separation during the maternal period.